Results 241 to 250 of about 662,606 (363)
ABSTRACT Hemodialysis (HD) patients are at higher risk of severe COVID‐19 and may exhibit suboptimal vaccine responses. This study evaluates the factors influencing vaccine‐induced immunity in HD patients following the second dose of the Vaxzevria. A total of 276 HD patients and 126 controls were included. Antibody responses were assessed using binding
Chia‐Wei Chang +9 more
wiley +1 more source
2026-2027 AAFP Immunization Schedules: What's New and Why It Matters For Family Medicine. [PDF]
Savoy M.
europepmc +1 more source
State Immunization Investments : Tennessee
Tennessee$101,435,767Vaccines for Children Program (VFC)Vaccines: $88,368,363Program Operations: $1,412,464Other Funding: $11,654,940Publication date from document properties.Tennessee-2019-CDC-Immunization-Investments ...
core
PRV-delgE/gI/TK immunization preserves blood-brain barrier integrity and limits CNS injury following intracerebral PRV challenge. [PDF]
Xu T +9 more
europepmc +1 more source
State Immunization Investments : Wyoming
Wyoming$7,030,090Vaccines for Children Program (VFC)Vaccines: $5,109,289Program Operations: $414,953Other Funding: $1,505,848Publication date from document properties.Wyoming-2019-CDC-Immunization-Investments ...
core
ABSTRACT Co‐administration of COVID‐19 and influenza vaccines has been promoted to improve coverage, but acceptance among healthcare workers (HCWs) remains uncertain. In total, 1238 participants were recruited. Participants were categorized by vaccination pattern including same‐day co‐administration, non‐concurrent vaccination, or single vaccine ...
Yu‐Yin Lin +11 more
wiley +1 more source
Accelerating Evidence-Informed Vaccine Introductions: Lessons from the Hexavalent Early Adopters Workshop. [PDF]
Hopkins KL +29 more
europepmc +1 more source
State Immunization Investments : Wisconsin
Wisconsin$54,242,313Vaccines for Children Program (VFC)Vaccines: $46,744,306Program Operations: $1,319,139Other Funding: $6,178,868Publication date from document properties.Wisconsin-2019-CDC-Immunization-Investments ...
core
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best +17 more
wiley +1 more source

